Gedeon Richter (company)
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
R&D center of Gedeon Richter plc in Budapest | |
| Company type | Public |
|---|---|
Traded as | BPSE: RICHTER BUX Component |
| Industry | Biotechnology Pharmaceuticals |
| Founded | 1901 |
| Founder | Gedeon Richter |
| Headquarters | |
Area served | Worldwide |
Key people | Erik Bogsch (Chairman) Gábor Orbán (CEO) |
| Products | Medicines Pharmaceuticals |
| Revenue | US$ 2.31 billion (2022) |
| US$ 276 million (2018) | |
Net income | US$ 121.8 million (2018) |
| Total assets | US$ 2.7 billion (2018) |
| Total equity | US$ 2.3 billion (2018) (on 288.9 USD/HUF) |
Number of employees | 12,696 (2018) |
| Subsidiaries | Helm BioTec Medimpex Preglem |
| Website | www.gedeonrichter.com |
| Footnotes / references | |
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women’s health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter (1872–1944), a pharmacist, in 1901.